<DOC>
	<DOCNO>NCT00941096</DOCNO>
	<brief_summary>The purpose study examine ocular hypotensive effect Bimatoprost potential additional effect Bimatoprost/Timolol fix combination eye ocular hypertension , primary open angle glaucoma exfoliation glaucoma .</brief_summary>
	<brief_title>Intraocular Pressure Reduction With Bimatoprost/Timolol Fixed Combination</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Primary open angle glaucoma Exfoliation glaucoma Ocular hypertension Younger 18 year old Inability understand and/or follow study requirement Women childbearing potential use reliable birth control , pregnant lactate woman History chronic obstructive pulmonary disease , heart failure , 2nd 3rd AV block Anticipated modification treatment systemic hypertension study period History ocular herpes , corneal scarring , conventional laser surgery macular pathology History allergy , poor tolerability poor response study medication Best correct visual acuity le 0.4 Significant visual field defect ( MD &lt; 15.0 dB )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Ocular Hypertension</keyword>
	<keyword>Lumigan</keyword>
	<keyword>Ganfort</keyword>
</DOC>